View Category:

Regulatory Alert: New FDA Proposed Rule — Sponsor Reporting of Falsified Data

Today the FDA has published a proposed rule in the Federal Register (75 FR 33 at 7412, 2/19/10) that will require sponsors (and defining petitioners under food/supplement submission rules as sponsors) to report to FDA any instance of falsified data that the sponsor company identifies within a proposed or current human or animal study in support of pharmaceutical, medical device,  food, color...
read more

Bioanalytical Quality Standard Initiative

Jack Garvey, Founder of Compliance Architects LLC is Co-Chair of the Bioanalytical Quality Standards Initiative.   This initiative, conceived by Synomics Pharma Services, was founded to respond to years of inconsistent guidance and enforcement surrounding bioanalysis in support of clinical trials.   Please contact Jack (see contact info below) for further information on this important...
read more